2seventy bio Forecast, price target & analysts
2seventy bio Target price 2025 - Analyst rating & recommendation
2seventy bio Classifications & Recommendation:
2seventy bio Price Target
| Target Price | $5.00 |
| Price | $4.97 |
| Potential |
0.60%
register free of charge
|
| Number of Estimates | 2 |
|
2 Analysts have issued a price target 2seventy bio 2026 .
The average 2seventy bio target price is $5.00.
This is
0.60%
register free of charge
$5.00
0.60%
register free of charge
$5.00
0.60%
register free of charge
|
|
| A rating was issued by 3 analysts: 0 Analysts recommend 2seventy bio to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the 2seventy bio stock has an average upside potential 2026 of
0.60%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 37.86 | 68.48 |
| 62.29% | 80.88% | |
| EBITDA Margin | -260.04% | -33.15% |
| 26.47% | 87.25% | |
| Net Margin | -149.89% | -30.13% |
| 34.01% | 79.90% |
4 Analysts have issued a sales forecast 2seventy bio 2025 . The average 2seventy bio sales estimate is
This results in the following potential growth metrics:
2 Analysts have issued an 2seventy bio EBITDA forecast 2025. The average 2seventy bio EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
4 2seventy bio Analysts have issued a net profit forecast 2025. The average 2seventy bio net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.10 | -0.40 |
| 75.11% | 63.64% | |
| P/E | negative | |
| EV/Sales | 4.81 |
4 Analysts have issued a 2seventy bio forecast for earnings per share. The average 2seventy bio EPS is
This results in the following potential growth metrics and future valuations:
Current 2seventy bio Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Mar 14 2025 |
| Leerink Partners |
Locked
➜
Locked
|
Locked | Mar 11 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Mar 14 2025 |
|
Locked
Leerink Partners:
Locked
➜
Locked
|
Mar 11 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
